For the Inventor, By the Inventor

Enter assignee name

Foster City, CA, United States of America

Neupharma, Inc.

USPTO Granted Patents = 41

EPO Patents = 13

Forward Citations = 217

Loading Chart...

Loading Chart...

3 inventors (with patents filed for the assignee):

Xiangping Qian (41 out of 92 patents)

Yong-Liang Zhu (29 out of 36 patents)

Yong-Iiang Zhu (1 out of 1 patent)

4. Yongliang Zhu (0 patent)

Core Competencies:

Substituted Quinazolines

Kinase Inhibitors

Benzenesulfonamide Derivatives

Quinoxaline

Pharmaceutical Compositions

Cancer Treatment

Chemical Entities

Steroids

41 patents: Sort by Forward Citations

1. 12403145 - Substituted quinazolines for inhibiting kinase activity (2025-09-02),

2. 12018002 - Certain chemical entities, compositions, and methods (2024-06-25),

3. 11865120 - Substituted quinazolines for inhibiting kinase activity (2024-01-09),

4. 11465975 - Certain chemical entities, compositions, and methods (2022-10-11),

5. 11325940 - Certain chemical entities, compositions, and methods (2022-05-10),

6. 11304957 - Substituted quinazolines for inhibiting kinase activity (2022-04-19),

7. 11208388 - Certain chemical entities, compositions, and methods (2021-12-28),

8. 10947201 - Certain chemical entities, compositions, and methods (2021-03-16),

9. 10766920 - Certain chemical entities, compositions, and methods (2020-09-08),

10. 10759766 - Certain chemical entities, compositions, and methods (2020-09-01),

11. 10653701 - Substituted quinazolines for inhibiting kinase activity (2020-05-19),

12. 10590106 - Certain chemical entities, compositions, and methods (2020-03-17),

13. 10561652 - Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer (2020-02-18),

14. 10544106 - Certain chemical entities, compositions, and methods (2020-01-28),

15. 10487108 - Certain steroids and methods for using the same in the treatment of cancer (2019-11-26),

NeuPharma, Inc. is a pharmaceutical company focused on the development and commercialization of innovative solutions for various healthcare needs. With a commitment to improving patient outcomes, we strive to bring novel therapies to market that address unmet medical needs. Our experienced team of scientists and researchers work tirelessly to advance our pipeline of drug candidates, leveraging cutting-edge technology and scientific expertise. Through strategic partnerships and collaborations, we aim to expand our reach and impact in the global healthcare industry. Visit our website to learn more about our company, products, and research initiatives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

41 Patents

#14 in Foster City, CA

#1,927 in California

#8,153 in US

#16,205 in the World

Foster City, CA, United States of America

Neupharma, Inc.

Forward Citations = 217

3 inventors:

Xiangping Qian (41 out of 92 patents)

Yong-Liang Zhu (29 out of 36 patents)

Yong-Iiang Zhu (1 out of 1 patent)

4. Yongliang Zhu (0 patent)

Please report any incorrect information to support@idiyas.com

Loading…